Skip to main content
Clinical Trials/NCT02589873
NCT02589873
Completed
Not Applicable

A Workplace Intervention Trial Comparing Two Diabetes Prevention Programs - In-person and Online - Delivered in a Large Urban Workplace Environment.

Kaiser Permanente1 site in 1 country157 target enrollmentSeptember 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diabetes Mellitus, Type 2
Sponsor
Kaiser Permanente
Enrollment
157
Locations
1
Primary Endpoint
Body weight lost
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

This study evaluates two group-based Diabetes Prevention Program (DPP) lifestyle interventions delivered in the workplace to individuals at risk for pre-diabetes: 1) an in-person group-based lifestyle intervention; and 2) an internet-based intervention delivered using an online platform with lifestyle coaching support. Eligible participants will be randomized equally to each intervention program (120 participants in each).

Detailed Description

The study seeks to compare weight loss, changes in physical activity and dietary fat intake, and participant engagement in two Diabetes Prevention Program (DPP) interventions derived from the Centers for Disease Control and Prevention (CDC) curriculum: an in-person and an internet-based intervention program. We hypothesize that the internet-based intervention will be more effective in achieving weight loss than the in-person intervention, given its convenience for participants to complete sessions and therefore greater potential engagement in the program.

Registry
clinicaltrials.gov
Start Date
September 2015
End Date
August 15, 2017
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Ethnicity: All ethnic groups;
  • Sex: all genders;
  • Age (as of date of enrollment): Lower age limit: 18 years; Upper age limit: NONE;
  • Body mass index ≥ 25.0 kg/m2; ≥23 kg/m2 if Asian
  • Having pre-diabetes based on a score of 9+ on the CDC pre-diabetes screener
  • Able and willing to enroll and provide written, informed consent, i.e., to:
  • meet the time and data collection requirements of the study;
  • be randomized to one of the two intervention programs;
  • adhere to the recommendations of the study intervention as assigned; and
  • participate in follow-up for 12 months.

Exclusion Criteria

  • Does not work at one of the participating employer work locations/departments;
  • Inability to speak, read, or understand English;
  • No regular access to a computer with internet capabilities;
  • Diagnosis of Type 1 or Type 2 diabetes mellitus;
  • Systolic blood pressure ≥ 180 mm Hg or diastolic blood pressure ≥ 100 mm Hg on more than one occasion during the last year;
  • Having a medical or physical condition that make moderate intensity physical activity (like a brisk walk) difficult or unsafe, such as exercise induced asthma or chronic obstructive pulmonary disease (COPD);
  • Use of weight-loss medications in the past 3 months;
  • Regular use (\> 5 days/month) of medications that affect appetite or weight (e.g., oral corticosteroids, insulin, oral hypoglycemics etc.);
  • Currently enrolled in a weight loss program;
  • Planning to undergo bariatric surgery during the study period;

Outcomes

Primary Outcomes

Body weight lost

Time Frame: 12 months

Percentage of body weight lost and the amount of weight lost (in pounds) on average over the 12 month follow-up, and at 6 and 12 months compared to baseline, by intervention arm. Body weight will be collected at baseline, 6 months, and 12 months.

Secondary Outcomes

  • Change in minutes of physical activity(12 months)
  • Participant engagement(12 months)
  • Change in dietary fat intake(12 months)
  • Stress and well-being(12 months)

Study Sites (1)

Loading locations...

Similar Trials